Skip to main content

Table 3 Factors associated with rtPA in the whole dyslipidemic stroke population.

From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia

 

B Value

Wald

Odds Ratio

95% C.I.

Lower

For OR

Upper

P Value

Age

0.012

2.210

1.012

0.996

1.028

0.137

BMI

-0.008

0.414

0.992

0.967

1.017

0.520

NIH Stroke Scale

-0.125

17.336

0.882

0.832

0.936

<0.001*

Risk of Mortality GWTG

0.069

3.302

1.071

0.995

1.153

0.069

Gender

0.516

8.838

1.675

1.192

2.354

0.003*

Race

0.181

0.821

1.198

0.810

1.773

0.365

Atrial Fibrillation

0.592

6.350

1.807

1.140

2.862

0.012*

Coronary Artery Disease

0.136

0.520

1.145

0.792

1.655

0.471

Carotid Artery Stenosis

1.108

10.309

3.030

1.540

5.960

0.001*

Diabetes

0.380

1.442

1.462

0.787

2.716

0.230

Congestive Heart Failure

0.260

0.979

1.296

0.775

2.168

0.322

Hypertension

-0.247

0.577

0.781

0.412

1.479

0.448

Previous Stroke

0.614

10.591

1.847

1.276

2.673

0.001*

Previous TIA

-0.311

1.514

0.733

0.447

1.202

0.219

Peripheral Vascular Disease

0.062

0.043

1.064

0.590

1.921

0.836

History of Smoking

-0.337

2.308

0.714

0.462

1.103

0.129

Antiplatelet medication

-0.291

2.188

0.747

0.508

1.099

0.139

Antihypertensive medication

-0.618

4.786

0.539

0.310

0.938

0.029*

Cholesterol Reducer

-0.187

0.813

0.829

0.552

1.246

0.367

Antidiabetic medication

-0.091

0.074

0.913

0.474

1.759

0.785

  1. Positive B values (Adj, OR > 1) denote variables more associated with rtPA exclusion while negative B values (Adj. OR < 1) denote variables more associated with rtPA inclusion. Hosmer-Lemeshow test (P = 0.826), Classification table (overall correctly classified percentage = 65.9%), and area under the ROC curve (AUC = 0.716) were applied to check the model fitness